Phase I long-term population pharmacokinetic trial of RHB 104.
Latest Information Update: 28 Oct 2016
At a glance
- Drugs Clarithromycin/clofazimine/rifabutin (Primary)
- Indications Crohn's disease
- Focus Pharmacokinetics; Registrational
- Sponsors RedHill Biopharma
- 07 Jan 2014 New trial record